Literature DB >> 12699015

Challenges in delivering antiretroviral treatment in resource poor countries.

Mina C Hosseinipour1, Peter N Kazembe, Ian M Sanne, Charles M van der Horst.   

Abstract

Mesh：

Substances：

Year:  2002        PMID： 12699015     DOI： 10.1097/00002030-200216004-00024

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  9 in total

1.  Patient volume, human resource levels, and attrition from HIV treatment programs in central Mozambique.

Authors:  Barrot H Lambdin; Mark A Micek; Thomas D Koepsell; James P Hughes; Kenneth Sherr; James Pfeiffer; Marina Karagianis; Joseph Lara; Stephen S Gloyd; Andy Stergachis
Journal:  J Acquir Immune Defic Syndr       Date:  2011-07-01       Impact factor: 3.731

2.  Effectiveness of a training program to increase the capacity of health care providers to provide HIV/AIDS care and treatment in Swaziland.

Authors:  H N Kamiru; M W Ross; L K Bartholomew; S A McCurdy; M W Kline
Journal:  AIDS Care       Date:  2009-11

3.  Quality of HIV care provided by non-physician clinicians and physicians in Mozambique: a retrospective cohort study.

Authors:  Kenneth H Sherr; Mark A Micek; Sarah O Gimbel; Stephen S Gloyd; James P Hughes; Grace C John-Stewart; Rosa M Manjate; James Pfeiffer; Noel S Weiss
Journal:  AIDS       Date:  2010-01       Impact factor: 4.177

4.  [Study of factors related to adherence to antiretroviral therapy among patients followed at HIV/AIDS Unit in the District Hospital of Dschang, Cameroon].

Authors:  François-Xavier Mbopi-Kéou; Lucienne Dempouo Djomassi; Francisca Monebenimp
Journal:  Pan Afr Med J       Date:  2012-06-29

5.  Rationing antiretroviral therapy for HIV/AIDS in Africa: choices and consequences.

Authors:  Sydney Rosen; Ian Sanne; Alizanne Collier; Jonathon L Simon
Journal:  PLoS Med       Date:  2005-09-20       Impact factor: 11.069

6.  Using nurses to identify HAART eligible patients in the Republic of Mozambique: results of a time series analysis.

Authors:  Sarah O Gimbel-Sherr; Mark A Micek; Kenneth H Gimbel-Sherr; Thomas Koepsell; James P Hughes; Katherine K Thomas; James Pfeiffer; Stephen S Gloyd
Journal:  Hum Resour Health       Date:  2007-02-28

7.  Slow Acceptance of Universal Antiretroviral Therapy (ART) Among Mothers Enrolled in IMPAACT PROMISE Studies Across the Globe.

Authors:  L Stranix-Chibanda; S Brummel; J Pilotto; M Mutambanengwe; V Chanaiwa; T Mhembere; M Kamateeka; J Aizire; G Masheto; R Chamanga; M Maluwa; S Hanley; E Joao; G Theron; N Nevrekar; M Nyati; B Santos; L Aurpibul; M Mubiana-Mbewe; R Oliveira; T Anekthananon; P Mlay; K Angelidou; C Tierney; L Ziemba; A Coletti; K McCarthy; M Basar; N Chakhtoura; R Browning; J Currier; M G Fowler; P Flynn
Journal:  AIDS Behav       Date:  2019-09

8.  Total Lymphocyte Count as surrogate marker for CD4 Cell Count in HIV-Infected Individuals in Gondar University Hospital, Northwest Ethiopia.

Authors:  Yitayih Wondimeneh; Getachew Ferede; Gizachew Yismaw; Dagnachew Muluye
Journal:  AIDS Res Ther       Date:  2012-07-15       Impact factor: 2.250

Review 9.  Gender distribution of adult patients on highly active antiretroviral therapy (HAART) in Southern Africa: a systematic review.

Authors:  Adamson S Muula; Thabale J Ngulube; Seter Siziya; Cecilia M Makupe; Eric Umar; Hans Walter Prozesky; Charles S Wiysonge; Ronald H Mataya
Journal:  BMC Public Health       Date:  2007-04-25       Impact factor: 3.295
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.